Dris, Baidido A.

HRN: 29-50-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/19/2026
08/19/2026
IV
4.5g
Q8
INTRAABDOMINAL INFECTION
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: